University Of Rijeka
Clinical trials sponsored by University Of Rijeka, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Poop pills could tame tough IBS – early trial underway Results expected Mar 2027 (estimated)
- Blood markers may reveal hidden risks in obesity Results expected Apr 2027 (estimated)
- Poop pills aim to stamp out superbugs in the gut Results expected Sep 2027 (estimated)
-
Poop pills aim to stamp out superbugs in the gut
Disease control Recruiting nowThis study tests whether capsules containing freeze-dried stool from healthy donors can safely remove multidrug-resistant organisms (MDROs) from the intestines of 48 adults who carry these bacteria without symptoms. Participants will take either the fecal transplant capsules or a…
Phase 1/2 • Sponsor: University of Rijeka • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Poop pills could tame tough IBS – early trial underway
Disease control Recruiting nowThis study tests whether capsules containing freeze-dried fecal matter from healthy donors can safely reduce symptoms in adults with irritable bowel syndrome (IBS) that hasn't responded to usual treatments. 70 participants will be randomly assigned to receive either the fecal tra…
Phase 1/2 • Sponsor: University of Rijeka • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Blood markers may reveal hidden risks in obesity
Knowledge-focused Recruiting nowThis study looks at two blood inflammation markers, SII and SIRI, to see if they can help predict metabolic problems like insulin resistance and fatty liver in people who are overweight or have obesity. Researchers will follow 200 adults for up to 3 years, tracking their diet, la…
Sponsor: University of Rijeka • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC